It only takes one conversation with Dr. Orit Markowitz to feel her passion for scarless skin cancer surgery come through, and with good reason. Her unique noninvasive techniques for diagnosing and treating basal and squamous cell skin cancers always result in a scar-free outcome. “My passion is detecting and treating skin cancer without cutting,” says the medical director and founder of OptiSkin. “I’ve performed these procedures since 2007, and have published many articles, along with five-year follow-up data on the topic. My clearance rates are very similar to surgery,” she says. Her continuous success rates are what has made her so well-known that patients fly from around the world to see her. “For imaging, I use a non-cutting biopsy device called a confocal microscope to diagnose the tumor. Then, for pretreatment margination, I use a noninvasive laser called optical coherence tomography, for which I’ve led the research on in the U.S. I then combine non-ablative lasers to remove most skin cancers without cutting, as well as any pre-cancer, sun damage and any underlying skin issues like rosacea, acne or surgical scars. My patients go home without a Band-Aid that same day.”
Education
Degree:
Drexel University College of Medicine
Residency:
Dermatology, Downstate University Medical Center, New York, NY,
Fellowship:
Fellowship with Alfred W. Kopf at NYU Langone Medical Center,
Fellowship:
Pigmented Lesion, Fellow,
Credentials
Board Certification:
American Board of Dermatology
Affiliation:
American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery
A Minute With
What do you love most about your profession?
What I love the most about dermatology is that when one of my patients comes to me with a concern, I’m able to deliver an immediate result.
NewBeauty uses cookies for various reasons, including to analyze
and improve its content and advertising. Please review our
Privacy Policy
and Terms of Use
for more about how we use this data. By continuing to use this site,
you agree to these policies.